Robert Orlowski, Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared on X:
“Myeloma Paper of the Day:
Study of 2nd primary cancers in lymphoplasmacytic lymphoma/Waldenström macroglobulinemia finds incidence 9.3%, 5, 14.6% 10 yrs; heme cas borderline excess risk driven by MDS; excess risk selective not broadly increased.”
Title: Second primary cancers in lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia—cumulative burden without generalized excess cancer risk
Authors: Lars Munksgaard, Lars Moeller Pedersen, Lise Mette Rahbek Gjerdrum
You can read the full article on British Journal of Haematology.
You can find other articles featuring Robert Orlowski on OncoDaily.
